At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 21, 2026 at 17:20 ET
Two insiders at PTC Therapeutics sold a total of $459K in open-market sales over a 7-day window. Director Michael Schmertzler sold $389K and EVP/CLO Mark Boulding sold $71K, with Boulding also exercising options. The total value is only ~0.008% of PTCT's $5.9B market cap, making this a trivial cluster by proportionality standards. The sales are routine and non-informative, no bearish signal from this activity.
- Two insiders sold a combined $459K in open-market sales over 7 days
- Director Michael Schmertzler sold $389K across multiple trades at ~$72
- EVP/CLO Mark Boulding sold $71K after exercising options at $25.69
- Total sales represent ~0.008% of PTCT's $5.9B market cap, trivial
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access